UY30530A1 - Forma farmacologica peroral para la anticoncepcion - Google Patents
Forma farmacologica peroral para la anticoncepcionInfo
- Publication number
- UY30530A1 UY30530A1 UY30530A UY30530A UY30530A1 UY 30530 A1 UY30530 A1 UY 30530A1 UY 30530 A UY30530 A UY 30530A UY 30530 A UY30530 A UY 30530A UY 30530 A1 UY30530 A1 UY 30530A1
- Authority
- UY
- Uruguay
- Prior art keywords
- peroral
- dienogest
- alpha
- conception
- daily dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Una forma farmacologica peroral para la anticoncepcion contiene como un componente de principio activo 17a(alfa)-cianometil-17-B-hidroxiestra-4,9-dien-3-ona (dienogest) en una dosificacion diaria de igual o menor que 2,0 mg y como otro componente de principio activo 17a(alfa)-etinilestradiol (etinilestradio) en una dosificacion diaria menor que 0,03 mg junto con uno o varios vehículos de aceptacion farmacéutica. El principio activo dienogest está contenido en forma cristalina con un tamano de partícula promedio de 25 a 70 um. El principio activo etinilestradiol se incorpora en forma micronizada o como solucion etanolica durante la granulacion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06016694A EP1886694B1 (de) | 2006-08-10 | 2006-08-10 | Perorale Arzneiform mit Dienogest und Ethinylestradiol zur Kontrazeption |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30530A1 true UY30530A1 (es) | 2008-03-31 |
Family
ID=37561777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30530A UY30530A1 (es) | 2006-08-10 | 2007-08-07 | Forma farmacologica peroral para la anticoncepcion |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1886694B1 (es) |
AR (1) | AR062323A1 (es) |
AT (1) | ATE432714T1 (es) |
CL (1) | CL2007002323A1 (es) |
CY (1) | CY1110348T1 (es) |
DE (1) | DE502006003892D1 (es) |
DK (1) | DK1886694T3 (es) |
DO (1) | DOP2007000122A (es) |
ES (1) | ES2327665T3 (es) |
HR (1) | HRP20090438T1 (es) |
NO (1) | NO20091057L (es) |
PE (1) | PE20080541A1 (es) |
PL (1) | PL1886694T3 (es) |
PT (1) | PT1886694E (es) |
SI (1) | SI1886694T1 (es) |
TW (1) | TW200817012A (es) |
UY (1) | UY30530A1 (es) |
WO (1) | WO2008017331A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010003711B4 (de) * | 2010-04-08 | 2015-04-09 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoffpartikel |
CN115487198B (zh) * | 2022-09-20 | 2024-01-02 | 华中药业股份有限公司 | 一种快溶出度的左炔诺孕酮制剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1216713A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
DE10218107A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
-
2006
- 2006-08-10 DE DE502006003892T patent/DE502006003892D1/de active Active
- 2006-08-10 SI SI200630376T patent/SI1886694T1/sl unknown
- 2006-08-10 DK DK06016694T patent/DK1886694T3/da active
- 2006-08-10 ES ES06016694T patent/ES2327665T3/es active Active
- 2006-08-10 PT PT06016694T patent/PT1886694E/pt unknown
- 2006-08-10 AT AT06016694T patent/ATE432714T1/de active
- 2006-08-10 PL PL06016694T patent/PL1886694T3/pl unknown
- 2006-08-10 EP EP06016694A patent/EP1886694B1/de active Active
-
2007
- 2007-04-26 WO PCT/EP2007/003662 patent/WO2008017331A2/de active Application Filing
- 2007-07-16 TW TW096125903A patent/TW200817012A/zh unknown
- 2007-08-07 UY UY30530A patent/UY30530A1/es unknown
- 2007-08-09 CL CL200702323A patent/CL2007002323A1/es unknown
- 2007-08-09 PE PE2007001064A patent/PE20080541A1/es not_active Application Discontinuation
- 2007-08-09 DO DO2007000122A patent/DOP2007000122A/es unknown
- 2007-08-10 AR ARP070103547A patent/AR062323A1/es not_active Application Discontinuation
-
2009
- 2009-03-09 NO NO20091057A patent/NO20091057L/no not_active Application Discontinuation
- 2009-08-13 HR HR20090438T patent/HRP20090438T1/xx unknown
- 2009-09-03 CY CY20091100928T patent/CY1110348T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL1886694T3 (pl) | 2009-11-30 |
PE20080541A1 (es) | 2008-07-10 |
NO20091057L (no) | 2009-03-09 |
ES2327665T3 (es) | 2009-11-02 |
HRP20090438T1 (en) | 2009-09-30 |
DK1886694T3 (da) | 2009-09-28 |
DOP2007000122A (es) | 2008-02-15 |
TW200817012A (en) | 2008-04-16 |
CL2007002323A1 (es) | 2008-02-15 |
ATE432714T1 (de) | 2009-06-15 |
DE502006003892D1 (de) | 2009-07-16 |
EP1886694A1 (de) | 2008-02-13 |
AR062323A1 (es) | 2008-10-29 |
EP1886694B1 (de) | 2009-06-03 |
SI1886694T1 (sl) | 2009-10-31 |
WO2008017331A2 (de) | 2008-02-14 |
PT1886694E (pt) | 2009-08-17 |
CY1110348T1 (el) | 2015-04-29 |
WO2008017331A3 (de) | 2009-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019246858A1 (en) | Therapeutic and Method of Use | |
PE20080273A1 (es) | Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico | |
UY30461A1 (es) | Composicion farmacéutica para la anticoncepcion y para reducir el riesgo de malformaciones congénitas. | |
UY29835A1 (es) | Formas de dosificación farmacéutica sólidas que comprenden 5-cloro-n-(((5s)-2-oxo-3-(4-(3-oxo-4-morfolinil)fenil)-1,3-oxazolidin-5-il)metil)-2-tiofenocarboxamida | |
PE20142101A1 (es) | Composiciones farmaceuticas de aliskiren | |
NZ602698A (en) | Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis | |
PE20070329A1 (es) | Composiciones con estrogenos y metodos terapeuticos para su uso | |
UY30530A1 (es) | Forma farmacologica peroral para la anticoncepcion | |
PE20090805A1 (es) | COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL | |
DOP2006000037A (es) | Forma farmacológica peroral sólida para la anticoncepción | |
UY29861A1 (es) | Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
EA200701389A1 (ru) | Твёрдая пероральная лекарственная форма для контрацепции | |
AR053545A1 (es) | Preparacion farmaceutica para la anticoncepcion oral | |
CR10912A (es) | Preparacion framaceutica para reducir la endometriosis | |
PE20060402A1 (es) | Combinacion farmaceutica de etinilestradiol y acetato de clormadinona | |
CR9240A (es) | Forma farmacologica peroral solida para la anticoncepcion | |
CL2012000499A1 (es) | Forma de dosificación farmacéutica sólida oral de liberación extendida que comprende una formulación matricial de liberación extendida que comprende 5 a 500 mg de clorhidrato de oxicodona y al menos 80 % (p/p) de oxido de polietileno (pm 1.000.000); y su uso para tratar el dolor (div. sol. n° 200702485). | |
UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
TH80558B (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
PE20091695A1 (es) | COMBINACION FARMACEUTICA DE DROSPIRENONA Y 17ß-ESTRADIOL | |
PE20090075A1 (es) | Combinacion de antagonista del receptor de progesterona con un agonista y un antagonista de la hormona liberadora de hormona luteinizante para usar en enfermedades mediadas por brca | |
UY28181A1 (es) | Una composición farmacéutica para ser usada como anticonceptivo | |
CU20090116A7 (es) | Preparación farmacéutica para reducir la endometriosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DESI | Application deemed to be withdrawn |
Effective date: 20090915 |